Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

US Patent 11992480 · Granted May 28, 2024

Estimated economic value: $23,322,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions of spironolactone for deep dermal drug delivery2025
Topical roflumilast aerosol foams2025
Method for reducing side effects from administration of phosphodiesterase-4 inhi2025
Inhibition of crystal growth of roflumilast2025
Topical roflumilast formulation having antifungal properties2025
Topical roflumilast formulation having improved delivery and plasma half-life2025
Devices and methods for the treatment of body surface disorders2025
Inhibition of crystal growth of roflumilast2025
Treatment of cutaneous disorders2025
Roflumilast formulations with an improved pharmacokinetic profile2025
Pharmaceutical compositions of roflumilast and solvents capable of dissolving hi2024
Laureth-4 containing topical formulations2024